See If You Qualify For The Migraine Research trial
The purpose of this clinical research study is to test if Fremanezumab is effective in Preventing Chronic Migraine in patients 6 to 17 years of age.
Qualified participants will receive:
- Study-related migraine treatment at no cost
- Study-related medical exams at no cost
- Compensation up to $250 for time and travel
How It Works
Subscribe to our newsletter
Get notified by email about our current and upcoming clinical studies. Receive articles of clinical news and blog updates.